Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic Memories in Systemic Sclerosis.

Laura Duffy1, Steven O'Reilly1

  • 1Faculty of Health and Life Sciences, Immunology and Cell Biology Group, Northumbria University, Ellison Building, Newcastle Upon Tyne, UK.

The Journal of Investigative Dermatology
|April 17, 2017
PubMed
Summary

Systemic sclerosis fibrosis is driven by memory CD8+ cytotoxic T cells. These cells release Interleukin-13 (IL-13), a key profibrotic factor, suggesting IL-13 as a therapeutic target for this autoimmune disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype.

Nature communications·2026
Same author

Targeting the cGAS-STING pathway for therapeutic gain in autoimmune inflammatory cutaneous diseases with a focus on systemic lupus erythematosus and systemic sclerosis.

The British journal of dermatology·2025
Same author

Pathogenic variants in the cohesin loader subunit MAU2 lead to a new Cornelia de Lange Syndrome subtype.

medRxiv : the preprint server for health sciences·2025
Same author

The Role of the Pulmonary Microenvironment in Driving Transition From Systemic Sclerosis to Systemic Sclerosis-Associated Interstitial Lung Disease.

The Journal of rheumatology·2025
Same author

A Long Stretch: IL-11 Drives Skin Regeneration.

The Journal of investigative dermatology·2025
Same author

Extracellular BAG3 is elevated in early diffuse systemic sclerosis.

Military Medical Research·2025

Area of Science:

  • Immunology
  • Dermatology
  • Fibrosis Research

Background:

  • Systemic sclerosis is an autoimmune disease causing skin fibrosis.
  • T-cell infiltration is a hallmark, but specific T-cell subsets driving fibrosis remain unidentified.

Purpose of the Study:

  • To identify the specific T-cell types responsible for mediating fibrosis in systemic sclerosis.
  • To investigate the role of Interleukin-13 (IL-13) in T-cell-driven fibrosis.

Main Methods:

  • Analysis of T-cell populations in affected tissues.
  • Measurement of cytokine secretion, specifically IL-13, by T cells.

Main Results:

  • Memory CD8+ cytotoxic T cells were identified as the primary mediators of fibrosis.

Related Experiment Videos

  • These cells secrete significantly higher amounts of the profibrotic cytokine IL-13.
  • Elevated IL-13 levels correlate with systemic sclerosis severity.

    • Conclusions:

    • Memory CD8+ cytotoxic T cells drive systemic sclerosis fibrosis through IL-13 secretion.
    • Targeting IL-13 presents a potential therapeutic strategy for managing systemic sclerosis.